SCHEMBL4929992

SCHEMBL4929992

CCOc1ccc(-n2c(=O)[nH]c3cc(Cl)ccc32)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.63
MEN1 O00255 3/20 0.63
LMNA P02545 1/20 0.63
L3MBTL1 Q9Y468 1/20 0.63
HRH3 Q9Y5N1 1/20 0.47
MAPT P10636 2/20 0.47
ALDH1A1 P00352 2/20 0.46
HTT P42858 2/20 0.46
TSHR P16473 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.45
MAOB P27338 2/20 0.45
HTR1A P08908 1/20 0.42
ADRA2A P08913 1/20 0.42
DRD2 P14416 1/20 0.42
HTR2A P28223 1/20 0.42
SLC6A4 P31645 1/20 0.42
DRD3 P35462 1/20 0.42
CA9 Q16790 1/20 0.42
PKM P14618 1/20 0.42
MAPK1 P28482 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4929970 0.90 L3MBTL1 (0.60) KMT2AMEN1LMNAL3MBTL1HRH3
SCHEMBL4933122 0.90 L3MBTL1 (0.60) KMT2AMEN1LMNAL3MBTL1HRH3
SCHEMBL4933166 0.90 MEN1 (0.49) KMT2AMEN1LMNAL3MBTL1MAPT
SCHEMBL4928439 0.86 MEN1 (0.50) KMT2AMEN1LMNAL3MBTL1HRH3
SCHEMBL4922001 0.84 MEN1 (0.59) KMT2AMEN1LMNAL3MBTL1HRH3
SCHEMBL14463860 0.82 HRH3 (0.46) KMT2AMEN1LMNAL3MBTL1HRH3
SCHEMBL4928761 0.80 L3MBTL1 (0.47) KMT2AMEN1LMNAL3MBTL1HRH3
SCHEMBL4931086 0.80 L3MBTL1 (0.47) KMT2AMEN1LMNAL3MBTL1HRH3
SCHEMBL28738835 0.78 MEN1 (1.00) KMT2AMEN1LMNAL3MBTL1ALDH1A1
SCHEMBL4931144 0.76 LMNA (0.48) KMT2AMEN1LMNAL3MBTL1HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080021069-A1 Receptor Function Regulating Agent TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-01-24 US disclosed
US-20080021069-A1 Receptor Function Regulating Agent TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-01-24 US disclosed
US-20080021069-A1 Receptor Function Regulating Agent TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-01-24 US disclosed
EP-1810677-A1 RECEPTOR FUNCTION REGULATING AGENT Takeda Pharmaceutical Company Limited (JP) 2007-07-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080021069-A1 Receptor Function Regulating Agent GPR119, INSR, GPR65 KMT2A 1963/4885MEN1 4097/4885LMNA 4744/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.